Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation

Tissue engineering focuses on the construction of three-dimensional neotissues from their cellular components. Neotissue can be used to repair or replace tissues that are missing, damaged, or diseased. Despite its relative youth, the field has undergone significant growth. Vascular tissue engineering is at the forefront in the translation of this technology, as tissue engineered vascular grafts have already been successfully implanted in children with congenital heart disease. The purpose of this report is to review the advances in the understanding of tissue engineered vascular grafts as the technology moves to clinical translation.

[1]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[2]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[3]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[4]  M S Conte,et al.  The ideal small arterial substitute: a search for the Holy Grail? , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  R. Gurny,et al.  Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. , 2012, Biomaterials.

[6]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[7]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[8]  Z. Galis,et al.  Remodeling of Carotid Artery Is Associated With Increased Expression of Matrix Metalloproteinases in Mouse Blood Flow Cessation Model , 2000, Circulation.

[9]  Narutoshi Hibino,et al.  Tissue‐engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Narutoshi Hibino,et al.  Determining the fate of seeded cells in venous tissue‐engineered vascular grafts using serial MRI , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[12]  C. Breuer,et al.  Challenges in translating vascular tissue engineering to the pediatric clinic , 2011, Vascular cell.

[13]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[14]  Narutoshi Hibino,et al.  Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. , 2011, Tissue engineering. Part C, Methods.

[15]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[16]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[17]  Narutoshi Hibino,et al.  A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling , 2010, Proceedings of the National Academy of Sciences.

[19]  A. Shiose,et al.  Excellent midterm outcome of extracardiac conduit total cavopulmonary connection: results of 126 cases. , 2007, The Annals of thoracic surgery.

[20]  N. Hibino,et al.  Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. , 2001, Tissue engineering.

[21]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[22]  Narutoshi Hibino,et al.  Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. , 2003, The Journal of thoracic and cardiovascular surgery.

[23]  S. Matsuda,et al.  Development of an operator-independent method for seeding tissue-engineered vascular grafts. , 2011, Tissue engineering. Part C, Methods.

[24]  M. Pera,et al.  Stem cells: The dark side of induced pluripotency , 2011, Nature.

[25]  Christopher Breuer,et al.  Artificial blood vessel: the Holy Grail of peripheral vascular surgery. , 2005, Journal of vascular surgery.

[26]  A. Turchetta,et al.  Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. , 2006, Journal of the American College of Cardiology.

[27]  R. Bonnel,et al.  What the Orphan Drug Act Has Done Lately for Children With Rare Diseases: A 10-Year Analysis , 2012, Pediatrics.

[28]  Matthew P. Brennan,et al.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. , 2008, Biomaterials.

[29]  Narutoshi Hibino,et al.  Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal Model , 2008, Annals of surgery.

[30]  Yadong Wang,et al.  Fast degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neo-artery , 2011, Nature Medicine.

[31]  Yuqiang Bai,et al.  Enabling tools for engineering collagenous tissues integrating bioreactors, intravital imaging, and biomechanical modeling , 2009, Proceedings of the National Academy of Sciences.

[32]  Misty J. Williams-Fritze,et al.  Characterization of the Natural History of Extracellular Matrix Production in Tissue-Engineered Vascular Grafts during Neovessel Formation , 2011, Cells Tissues Organs.

[33]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts: does cell seeding matter? , 2010, Journal of pediatric surgery.

[34]  J D Humphrey,et al.  A multiaxial computer-controlled organ culture and biomechanical device for mouse carotid arteries. , 2004, Journal of biomechanical engineering.

[35]  Narutoshi Hibino,et al.  Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. , 2009, Journal of pediatric surgery.

[36]  Soo-jin Kim,et al.  Outcome of 200 patients after an extracardiac Fontan procedure. , 2008, The Journal of thoracic and cardiovascular surgery.

[37]  M. Voskuil,et al.  Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. , 2003, American journal of physiology. Heart and circulatory physiology.

[38]  Narutoshi Hibino,et al.  Late-term results of tissue-engineered vascular grafts in humans. , 2010, The Journal of thoracic and cardiovascular surgery.